Tobe K, Kadowaki T, Hara K, Gotoh Y, Kosako H, Matsuda S, Tamemoto H, Ueki K, Akanuma Y, Nishida E
Third Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Japan.
J Biol Chem. 1992 Oct 15;267(29):21089-97.
An insulin-stimulated phosphorylation cascade was examined in rat liver after insulin injection via a portal vein by the use of immune complex kinase assays specific to the mitogen-activated protein (MAP) kinase and S6 kinase II homologue (rsk) kinase. We have prepared an antibody against the peptide consisting of a carboxyl-terminal portion of the extracellular signal-regulated kinase 1 (alpha C92), one of the MAP kinases, and an antibody against the peptide consisting of the carboxyl terminus of the mouse S6 kinase II homologue (alpha rsk(m)C). In alpha C92 immune complex assay, maximal activation of rat liver MAP kinases (approximately 4.3-fold) were observed 4.5 min after insulin injection. We also observed an insulin-stimulated MAP kinase activity (approximately 3-fold) in liver extracts from insulin-treated rat in fractions eluted from phenyl-Sepharose with 30-50% ethylene glycol. Kinase assay in myelin basic protein (MBP)-containing gel after sodium dodecyl sulfate-polyacrylamide gel electrophoresis followed by denaturation with 6 M guanidine HCl, and renaturation revealed that insulin injection stimulated the kinase activity of the 42- and 44-kDa proteins, which corresponded to the two distinct MAP kinases. In alpha rsk(m)C immune complex assay, maximal stimulation (approximately 5-fold) of the S6 peptide (Arg-Arg-Leu-Ser-Ser-Leu-Arg-Ala) kinase activity was observed 7.5 min after insulin injection. In addition, MAP kinases purified from insulin-treated rat liver were able to activate S6 peptide kinase activity in vitro in alpha rsk(m)C immunoprecipitates from untreated rat liver, accompanied by the appearance of several phosphorylated bands including a major band at 88 kDa. We also examined whether insulin injection stimulates the MAP kinase activator (Ahn, N. G., Seger, R., Bratlien, R. L., Diltz, C. D., Tonks, N. K., and Krebs, E. G. (1991) J. Biol. Chem. 266, 4220-4227) in rat liver. Using recombinant Xenopus MAP kinase, fractions of Q-Sepharose eluted early in the NaCl gradient were found to have MAP kinase activator activity accompanied by the phosphorylation of 42-kDa recombinant Xenopus MAP kinase. From these data, we demonstrate three tiers of a cascade composed of the MAP kinase activator, MAP kinases, and an S6 peptide kinase activity in rat liver under physiological conditions in the intact animal.
通过使用针对丝裂原活化蛋白(MAP)激酶和S6激酶II同源物(rsk)激酶的免疫复合物激酶测定法,研究了经门静脉注射胰岛素后大鼠肝脏中胰岛素刺激的磷酸化级联反应。我们制备了一种针对由MAP激酶之一细胞外信号调节激酶1(αC92)的羧基末端部分组成的肽的抗体,以及一种针对由小鼠S6激酶II同源物(αrsk(m)C)的羧基末端组成的肽的抗体。在αC92免疫复合物测定中,胰岛素注射后4.5分钟观察到大鼠肝脏MAP激酶的最大激活(约4.3倍)。我们还在从用30 - 50%乙二醇从苯基琼脂糖洗脱的级分中,观察到胰岛素处理大鼠肝脏提取物中的胰岛素刺激的MAP激酶活性(约3倍)。在十二烷基硫酸钠 - 聚丙烯酰胺凝胶电泳后,在含髓鞘碱性蛋白(MBP)的凝胶中进行激酶测定,然后用6 M盐酸胍变性并复性,结果显示胰岛素注射刺激了42 kDa和44 kDa蛋白质的激酶活性,这两种蛋白质对应于两种不同的MAP激酶。在αrsk(m)C免疫复合物测定中,胰岛素注射后7.5分钟观察到S6肽(Arg - Arg - Leu - Ser - Ser - Leu - Arg - Ala)激酶活性的最大刺激(约5倍)。此外,从胰岛素处理的大鼠肝脏中纯化的MAP激酶能够在体外激活来自未处理大鼠肝脏的αrsk(m)C免疫沉淀物中的S6肽激酶活性,同时出现几条磷酸化条带,包括一条88 kDa的主要条带。我们还研究了胰岛素注射是否刺激大鼠肝脏中的MAP激酶激活剂(安,N.G.,塞格,R.,布拉特利恩,R.L.,迪尔茨,C.D.,汤克斯,N.K.,和克雷布斯,E.G.(1991)《生物化学杂志》266,4220 - 4227)。使用重组非洲爪蟾MAP激酶,发现在NaCl梯度早期从Q - 琼脂糖洗脱的级分具有MAP激酶激活剂活性,并伴随着42 kDa重组非洲爪蟾MAP激酶的磷酸化。从这些数据中,我们证明了在完整动物的生理条件下,大鼠肝脏中由MAP激酶激活剂、MAP激酶和S6肽激酶活性组成的三级级联反应。